Abstract
Objectives
The European Working Group on Sarcopenia in Older People (EWGSOP) has proposed different methods and cut-off points for the three parameters that define sarcopenia: muscle mass, muscle strength and physical performance. Although this facilitates clinical practice, it limits comparability between studies and leads to wide differences in published prevalence rates. The aim of this study was to assess how changes in cut-off points for muscle mass, gait speed and grip strength affected sarcopenia prevalence according to EWGSOP criteria.
Methods
Cross-sectional analysis of elderly individuals recruited from outpatient clinics (n=298) and nursing homes (n=276). We measured muscle mass, grip strength and gait speed and assessed how changes in cut-off points changed sarcopenia prevalence in both populations.
Results
An increase from 5.45 kg/m2 to 6.68 kg/m2 in the muscle mass index for female outpatients and nursing-home residents increased sarcopenia prevalence from 4% to 23% and from 9% to 47%, respectively; for men, for an increase from 7.25 kg/m2 to 8.87 kg/m2, the corresponding increases were from 1% to 22% and from 6% to 41%, respectively. Changes in gait speed and grip strength had a limited impact on sarcopenia prevalence.
Conclusion
The cut-off points used for muscle mass affect the reported prevalence rates for sarcopenia and, in turn, affect comparability between studies. The main factors influencing the magnitude of the change are muscle mass index distribution in the population and the absolute value of the cut-off points: the same difference between two references (e.g., 7.5 kg/m2 to 7.75 kg/m2 or 7.75 kg/m2 to 8 kg/m2) may produce different changes in prevalence. Changes in cut-off points for gait speed and grip strength had a limited impact on sarcopenia prevalence and on study comparability.
Similar content being viewed by others
References
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European con-sensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. 2010;Age Ageing doi:10.1093/ageing/afq034
Cruz-Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interven-tions for sarcopenia in ageing adults: a systematic review. Report of the Interna-tional Sarcopenia Initiative (EWGSOP and IWGS). 2014; Age Ageing doi:10.1093/ageing/ afu115
Bijlsma AY, Meskers CGM, Ling CHY, et al. Defining sarcopenia: the im-pact of different diagnostic criteria on the prevalence of sarcopenia in a large mid-dle aged cohort. 2013; AGE doi:10.1007/s11357-012-9384-z
Reijnierse EM, Trappenburg MC, Leter MJ, et al. The Impact of Different Diagnostic Criteria on the Prevalence of Sarcopenia in Healthy Elderly Partici-pants and Geriatric Outpatients. 2015;Gerontology doi:10.1159/000377699
Beaudart C, Reginster J-Y, Slomian J, Buckinx F, Locquet M, Bruyère O. Prevalence of sarcopenia: the impact of different diagnostic cut-off limits. J Musculoskelet Neuronal Interact. 14(4):425-431.
Osuna-Pozo CM, Serra-Rexach JA, Viña J, et al. Prevalencia de sarcopenia en consultas de geriatría y residencias. Estudio ELLI.Rev. Esp. 2014;Geriatría Gerontol. doi:10.1016/j.regg.2013.01.006
Cuesta F, Formiga F, Lopez-soto A, et al. Prevalence of Sarcopenia in Pa-tients Attending Outpatient Geriatric Clinics. The ELLI Study. 2015;Age Ageing doi:10.1093/ageing/afv088
Salvà A, Serra-Rexach JA, Artaza I, et al. La prevalencia de sarcopenia en residencias de España: comparación de los resultados del estudio multicéntrico ELLI con otras poblaciones.Rev. Esp. 2016;Geriatría Gerontol. doi:10.1016/j.regg.2016.02.004
Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical perfor-mance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49(2):M85–94.
Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol. 2000;89(2):465–471.
Masanes Toran F, Culla A, Navarro-González M, et al. Prevalence of sarco-penia in healthy community-dwelling elderly in an urban area of Barcelona (Spain). J. Nutr. Health Aging 2012;doi:10.1007/s12603-011-0108-3
Kelly TL, Wilson KE, Heymsfield SB. Dual Energy X-Ray Absorptiometry Body Composition Reference Values from NHANES. Vella A, ed. PLoS ONE, 2009; doi:10.1371/journal.pone.0007038
Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of Sarco-penia among the Elderly in New Mexico. Am J Epidemiol. 1998;147(8):755–763.
Delmonico MJ, Harris TB, Visser M, et al. Longitudinal study of muscle strength, quality, and adipose tissue infiltration.Am.. Clin. Nutr. 2009; doi:10.3945/ajcn.2009.28047
Janssen I. Skeletal Muscle Cutpoints Associated with Elevated Physical Disability Risk in Older Men and Women.Am. 2004;J. Epidemiol. doi:10.1093/aje/kwh058
Tichet J, Vol S, Goxe D, Salle A, Berrut G, Ritz P. Prevalence of sarcopenia in the French senior population. J Nutr Health Aging. 2008;12(3):202–206.
Chien M-Y, Huang T-Y, Wu Y-T. Prevalence of Sarcopenia Estimated Us-ing a Bioelectrical Impedance Analysis Prediction Equation in Community-Dwelling Elderly People in Taiwan.J.Am. Geriatr. Soc. 2008; doi:10.1111/j.1532-5415.2008.01854.x
Landi F, Liperoti R, Fusco D, et al. Prevalence and Risk Factors of Sarco-penia Among Nursing Home Older Residents.J. Gerontol. A. Biol. Sci. Med. Sci. 2012; doi:10.1093/gerona/glr035
Fried LP, Tangen CM, Walston J, et al. Frailty in Older Adults: Evidence for a Phenotype. J Gerontol Biol Sci Med Sci. 2001;56(3):M146–157.
McLean RR, Shardell MD, Alley DE, et al. Criteria for Clinically Relevant Weakness and Low Lean Mass and Their Longitudinal Association With Incident Mobility Impairment and Mortality: The Foundation for the National Institutes of Health (FNIH) Sarcopenia Project.J. Gerontol. A. Biol. Sci. Med, 2014;. Sci. doi:10.1093/ gerona/glu012
Alley DE, Shardell MD, Peters KW, et al. Grip Strength Cutpoints for the Identification of Clinically Relevant Weakness.J. Gerontol.A. Biol. Sci. Med. Sci. 2014; doi:10.1093/gerona/glu011
Chen L, Nelson DR, Zhao Y, Cui Z, Johnston JA. Relationship between muscle mass and muscle strength, and the impact of comorbidities: a population-based, cross-sectional study of older adults in the United States. BMC Geriatr. 2013; doi:10.1186/1471-2318-13-74
de Souza Vasconcelos KS, Domingues Dias JM, de Carvalho Bastone A, et al. Handgrip strength cutoff points to identify mobility limitation in com-munitydwelling older people and associated factors. J. Nutr. Health Aging 2016; doi:10.1007/ s12603-015-0584-y
Htun NC, Ishikawa-Takata K, Kuroda A, et al. Screening for malnutrition in community dwelling older Japanese: Preliminary development and evaluation of the Japanese Nutritional Risk Screening Tool (NRST).J. Nutr. Health Aging 2016; doi:10.1007/s12603-015-0555-3
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Masanés, F., Rojano i Luque, X., Salvà, A. et al. Cut-off points for muscle mass — not grip strength or gait speed — determine variations in sarcopenia prevalence. J Nutr Health Aging 21, 825–829 (2017). https://doi.org/10.1007/s12603-016-0844-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-016-0844-5